- Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
-
Narayan V, Mamtani R, Keefe S, Guzzo T, Malkowicz , Vaughn DJ
- KMID: 2344082
- Cancer Res Treat.
- 2016 Jul;48(3):1084-1091.
- doi: 10.4143/crt.2015.405
PURPOSE: We sought to investigate the safety and efficacy of gemcitabine, cisplatin, and lapatinib (GCL) as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) planned for radical cystectomy. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
-
Han MA, Maisch P, Jung JH, Hwang JE, Narayan V, Cleves A, Hwang EC, Dahm P
- KMID: 2521813
- Investig Clin Urol.
- 2021 Nov;62(6):623-630.
- doi: 10.4111/icu.20210265
Purpose: To assess the comparative effectiveness and toxicity of intravesical gemcitabine instillation for non-muscle invasive bladder cancer (NMIBC). Materials and Methods: We performed a comprehensive literature search on 11 September 2020.... -
- CITED
-
- Close
- SHARE
-
- Close
